BeiGene Net Income vs Capital Expenditures Analysis

688235 Stock

176.00 0.32 0.18%

BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Net Income and its Capital Expenditures accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Net Income vs Capital Expenditures

Net Income vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Net Income account and Capital Expenditures. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between BeiGene's Net Income and Capital Expenditures is -0.38. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Net Income and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of BeiGene are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Net Income i.e., BeiGene's Net Income and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

-0.38

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in BeiGene financial statement analysis. It represents the amount of money remaining after all of BeiGene operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Capital Expenditures

Capital Expenditures are funds used by BeiGene to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of BeiGene operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.As of November 29, 2024, Tax Provision is expected to decline to about 29.8 M. In addition to that, Selling General Administrative is expected to decline to about 1 B

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.6B	3.2B	3.7B	2.8B
Cost Of Revenue	164.9M	286.5M	379.9M	304.1M

Total Operating Expenses Cost Of Revenue

BeiGene fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Other Current Liab	Property Plant And Equipment Net	Long Term Investments
Total Assets		0.96	1.0	-0.84	0.94	0.95	0.8	0.97	-0.87	0.84	-0.43	0.97	0.51	0.94	0.94	0.84	0.98	1.0	1.0	0.93	-0.67	0.97	0.88	-0.57	0.69	0.9
Total Current Liabilities	0.96		0.93	-0.93	0.99	0.95	0.94	0.94	-0.86	0.85	-0.54	0.99	0.33	0.81	0.85	0.96	0.99	0.95	0.92	1.0	-0.81	0.86	0.94	-0.76	0.86	0.92
Total Stockholder Equity	1.0	0.93		-0.81	0.91	0.94	0.76	0.97	-0.85	0.83	-0.4	0.95	0.55	0.96	0.95	0.8	0.97	1.0	1.0	0.9	-0.64	0.99	0.85	-0.51	0.64	0.89
Retained Earnings	-0.84	-0.93	-0.81		-0.95	-0.88	-0.95	-0.83	0.86	-0.74	0.75	-0.94	-0.04	-0.65	-0.77	-0.94	-0.9	-0.83	-0.79	-0.95	0.92	-0.71	-0.92	0.87	-0.93	-0.91
Accounts Payable	0.94	0.99	0.91	-0.95		0.93	0.95	0.94	-0.87	0.78	-0.56	0.99	0.3	0.78	0.83	0.95	0.98	0.93	0.9	1.0	-0.83	0.83	0.92	-0.77	0.88	0.9
Cash	0.95	0.95	0.94	-0.88	0.93		0.86	0.88	-0.75	0.89	-0.43	0.94	0.28	0.82	0.96	0.9	0.95	0.95	0.93	0.92	-0.83	0.89	0.96	-0.62	0.78	0.98
Non Current Assets Total	0.8	0.94	0.76	-0.95	0.95	0.86		0.79	-0.74	0.77	-0.61	0.91	0.03	0.57	0.69	0.99	0.89	0.79	0.74	0.96	-0.92	0.64	0.94	-0.9	0.98	0.88
Non Currrent Assets Other	0.97	0.94	0.97	-0.83	0.94	0.88	0.79		-0.92	0.71	-0.44	0.97	0.58	0.92	0.86	0.81	0.97	0.97	0.97	0.93	-0.62	0.94	0.8	-0.56	0.67	0.81
Long Term Debt	-0.87	-0.86	-0.85	0.86	-0.87	-0.75	-0.74	-0.92		-0.62	0.72	-0.9	-0.42	-0.83	-0.73	-0.74	-0.88	-0.86	-0.85	-0.87	0.59	-0.82	-0.71	0.68	-0.66	-0.73
Net Receivables	0.84	0.85	0.83	-0.74	0.78	0.89	0.77	0.71	-0.62		-0.45	0.79	0.2	0.74	0.82	0.83	0.85	0.84	0.82	0.81	-0.71	0.78	0.92	-0.65	0.72	0.91
Good Will	-0.43	-0.54	-0.4	0.75	-0.56	-0.43	-0.61	-0.44	0.72	-0.45		-0.55	0.28	-0.33	-0.36	-0.58	-0.51	-0.43	-0.39	-0.57	0.63	-0.32	-0.56	0.84	-0.68	-0.56
Common Stock Shares Outstanding	0.97	0.99	0.95	-0.94	0.99	0.94	0.91	0.97	-0.9	0.79	-0.55		0.37	0.84	0.88	0.92	0.99	0.96	0.94	0.99	-0.79	0.89	0.91	-0.72	0.82	0.91
Short Term Investments	0.51	0.33	0.55	-0.04	0.3	0.28	0.03	0.58	-0.42	0.2	0.28	0.37		0.7	0.39	0.07	0.42	0.53	0.58	0.3	0.25	0.64	0.08	0.25	-0.16	0.11
Non Current Liabilities Total	0.94	0.81	0.96	-0.65	0.78	0.82	0.57	0.92	-0.83	0.74	-0.33	0.84	0.7		0.89	0.62	0.88	0.95	0.97	0.77	-0.4	0.99	0.69	-0.34	0.42	0.75
Capital Lease Obligations	0.94	0.85	0.95	-0.77	0.83	0.96	0.69	0.86	-0.73	0.82	-0.36	0.88	0.39	0.89		0.75	0.89	0.94	0.94	0.81	-0.68	0.94	0.85	-0.43	0.59	0.92
Inventory	0.84	0.96	0.8	-0.94	0.95	0.9	0.99	0.81	-0.74	0.83	-0.58	0.92	0.07	0.62	0.75		0.92	0.83	0.79	0.96	-0.92	0.7	0.97	-0.86	0.96	0.92
Total Liab	0.98	0.99	0.97	-0.9	0.98	0.95	0.89	0.97	-0.88	0.85	-0.51	0.99	0.42	0.88	0.89	0.92		0.98	0.96	0.98	-0.75	0.92	0.92	-0.7	0.8	0.92
Net Invested Capital	1.0	0.95	1.0	-0.83	0.93	0.95	0.79	0.97	-0.86	0.84	-0.43	0.96	0.53	0.95	0.94	0.83	0.98		1.0	0.93	-0.66	0.98	0.87	-0.56	0.68	0.9
Total Current Assets	1.0	0.92	1.0	-0.79	0.9	0.93	0.74	0.97	-0.85	0.82	-0.39	0.94	0.58	0.97	0.94	0.79	0.96	1.0		0.89	-0.61	0.99	0.83	-0.49	0.61	0.87
Capital Stock	0.93	1.0	0.9	-0.95	1.0	0.92	0.96	0.93	-0.87	0.81	-0.57	0.99	0.3	0.77	0.81	0.96	0.98	0.93	0.89		-0.82	0.83	0.93	-0.8	0.89	0.9
Non Current Liabilities Other	-0.67	-0.81	-0.64	0.92	-0.83	-0.83	-0.92	-0.62	0.59	-0.71	0.63	-0.79	0.25	-0.4	-0.68	-0.92	-0.75	-0.66	-0.61	-0.82		-0.51	-0.91	0.84	-0.95	-0.89
Net Working Capital	0.97	0.86	0.99	-0.71	0.83	0.89	0.64	0.94	-0.82	0.78	-0.32	0.89	0.64	0.99	0.94	0.7	0.92	0.98	0.99	0.83	-0.51		0.77	-0.38	0.5	0.82
Intangible Assets	0.88	0.94	0.85	-0.92	0.92	0.96	0.94	0.8	-0.71	0.92	-0.56	0.91	0.08	0.69	0.85	0.97	0.92	0.87	0.83	0.93	-0.91	0.77		-0.79	0.9	0.98
Other Current Liab	-0.57	-0.76	-0.51	0.87	-0.77	-0.62	-0.9	-0.56	0.68	-0.65	0.84	-0.72	0.25	-0.34	-0.43	-0.86	-0.7	-0.56	-0.49	-0.8	0.84	-0.38	-0.79		-0.94	-0.71
Property Plant And Equipment Net	0.69	0.86	0.64	-0.93	0.88	0.78	0.98	0.67	-0.66	0.72	-0.68	0.82	-0.16	0.42	0.59	0.96	0.8	0.68	0.61	0.89	-0.95	0.5	0.9	-0.94		0.83
Long Term Investments	0.9	0.92	0.89	-0.91	0.9	0.98	0.88	0.81	-0.73	0.91	-0.56	0.91	0.11	0.75	0.92	0.92	0.92	0.9	0.87	0.9	-0.89	0.82	0.98	-0.71	0.83

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:

How To Invest In BeiGene

Details

Is BeiGene Stock a good investment?

Details

What is BeiGene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene Net Income vs Capital Expenditures Analysis

Net Income vs Capital Expenditures

Net Income vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Net Income

Capital Expenditures

BeiGene fundamental ratios Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Capital Stock	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Property Plant And Equipment Net	- 0.95	Non Current Liabilities Other
Capital Stock	- 0.95	Retained Earnings
Non Current Assets Total	- 0.95	Retained Earnings
Accounts Payable	- 0.95	Retained Earnings
Property Plant And Equipment Net	- 0.94	Other Current Liab
Inventory	- 0.94	Retained Earnings